Genmab

person throwing away garbage or recycling
Biotech

J&J junks $1.2B eczema therapy while Genmab drops cancer drug

Johnson & Johnson and Genmab both used the festive period to junk therapies that haven’t lived up to their promise in the clinic.
James Waldron Jan 2, 2026 9:05am
scrapheap

Genmab sheds another clinical ADC from $1.8B ProfoundBio buy

Nov 17, 2025 2:17pm
MA strategy deal block push come together form

Genmab pays $8B to buy Merus and phase 3 bispecific

Sep 29, 2025 5:38am
RD oil pipeline

Genmab discards ADC from $1.8B ProfoundBio buy

Sep 16, 2025 10:33am
parachutes sky italy sun blue

Pfizer’s reputation wrangler plans departure—Chutes & Ladders

Jul 11, 2025 8:30am
An arrow incrementally going up stairs before pointing straight up Blue background

Endometrial cancer data on Genmab's Elahere rival beat forecast

May 23, 2025 9:22am